Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
TNFRSF8 overexpression
i
Other names:
TNFRSF8, TNF Receptor Superfamily Member 8, Tumor Necrosis Factor Receptor Superfamily Member 8, Lymphocyte Activation Antigen CD30, CD30L Receptor, Ki-1 Antigen, D1S166E, CD30, Tumor Necrosis Factor Receptor Superfamily, Member 8, Cytokine Receptor CD30, CD30 Antigen, TNFRSF8, Ki-1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
943
Related biomarkers:
Expression
Others
‹
TNFRSF8 positive (16)
TNFRSF8 expression (12)
TNFRSF8 negative (2)
CD20 expression + TNFRSF8 overexpression (1)
CD20 positive + MME positive + TNFRSF8 negative (1)
TNFRSF8 positive (16)
TNFRSF8 expression (12)
TNFRSF8 negative (2)
CD20 expression + TNFRSF8 overexpression (1)
CD20 positive + MME positive + TNFRSF8 negative (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
TNFRSF8 overexpression
Hodgkin Lymphoma
TNFRSF8 overexpression
Hodgkin Lymphoma
nivolumab + brentuximab vedotin
Sensitive: C3 – Early Trials
nivolumab + brentuximab vedotin
Sensitive
:
C3
nivolumab + brentuximab vedotin
Sensitive: C3 – Early Trials
nivolumab + brentuximab vedotin
Sensitive
:
C3
TNFRSF8 overexpression
Lymphoma
TNFRSF8 overexpression
Lymphoma
brentuximab vedotin
Sensitive: C4 – Case Studies
brentuximab vedotin
Sensitive
:
C4
brentuximab vedotin
Sensitive: C4 – Case Studies
brentuximab vedotin
Sensitive
:
C4
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login